Read + Share
. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like
peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and
network meta-analysis of randomised controlled trials. BMJ 2022;376:o109.
PMID: 35044930
|
 |
|
